Trial Profile
Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Choroidal neovascularisation; Myopia
- Focus Therapeutic Use
- Acronyms AflibxMyopia
- 11 Feb 2014 New trial record